Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
C. Camaschella, A. Piperno.
Hereditary hemochromatosis: recent advances in molecular genetics and clinical management.
Hematologica, 82 (1997), pp. 77-84
[2.]
G.M. Brittenham.
Disorders of iron metabolism: iron deficiency and overload.
Hematology basic principles and practice, pp. 327-349
[3.]
J.M. Lazarus, R.M. Hakim, J. Newell.
Recombinant human erythropoeitin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients.
Am J Kidney Dis, 16 (1990), pp. 101-108
[4.]
S. De Marchi, E. Cecchin.
Hepatic computed tomography for monitoring the iron status of haemodialysis patients whit haemosiderosis treated with recombinant human erythropoietin.
Clin Sci, 81 (1991), pp. 113-121
[5.]
M. De Gobbi, P. Pasquero, F. Brunello, P. Paccotti, U. Mazza, C. Camaschella.
Juvenile hemochromatosis associated with B-thalassemia treated by phlebotomy and recombinant human erythropoietin.
Haematologica, 85 (2000), pp. 865-867
[6.]
A. Kohan, R. Niborski, J. Daruich, J. Rey, F. Bastos, G. Amerise, et al.
Erythrocytapheresis with recombinant human erythropoietin in hereditary hemochromatosis therapy: a new alternative.
Vox Sang, 79 (2000), pp. 40-45
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados
